MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

August 30, 2017

Yury*, 38, is celebrating a moment he thought would never arrive: he has been cured of extensively drug-resistant tuberculosis (XDR-TB). This moment is also a milestone for Doctors Without Borders/Médecins Sans Frontières (MSF): Yury is the first patient to complete MSF’s tuberculosis treatment program in Belarus, run in close cooperation with the Ministry of Health.

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

April 21, 2016

The earthquakes that ratted southwestern Japan last week injured around 1,100 people in Kumamoto and Oita prefectures and led to the deaths of another 58. Roughly 103,000 people remained displaced in Kumamoto and around 600 in Oita, and the authorities are still searching for people who are unaccounted for as well. What's more, due to heavy rains and the subsequent risk of landslides, some 240,000 people have been advised to evacuate 19 cities, towns and villages in Kumamoto and Oita.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

April 13, 2012

Chagas is a neglected disease that affects between eight and ten million people, mainly in Latin America. Doctors Without Borders/Médecins Sans Frontières (MSF) works in Paraguay's rural Chaco region, going into isolated communities to educate people about the disease and screen them for it. Internationally, MSF fights to improve access to diagnosis and treatment for the disease and advocates for more research and development into its treatment.

All photos by Anna Surinyach

April 05, 2012

In Paraguay, Doctors Without Borders/Médecins Sans Frontières (MSF) is covering the rural Chaco region, encouraging people to be tested and treated for Chagas, a widespread but little known and potentially fatal disease.

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

October 04, 2011

This crisis could have been prevented but the major player involved, the Brazilian Ministry of Health, has shirked its responsibilities and is evidently unwilling to overcome the various challenges. 

October 03, 2011

Chagas disease, or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi (T. cruzi) and is transmitted mainly by insects called triatomines, also known as ‘assassin bugs’ or ‘kissing bugs’. It is endemic in 21 Latin American countries and cases have also been reported in the U.S., Europe, and Japan.

Pages

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

August 30, 2017

Yury*, 38, is celebrating a moment he thought would never arrive: he has been cured of extensively drug-resistant tuberculosis (XDR-TB). This moment is also a milestone for Doctors Without Borders/Médecins Sans Frontières (MSF): Yury is the first patient to complete MSF’s tuberculosis treatment program in Belarus, run in close cooperation with the Ministry of Health.

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

April 21, 2016

The earthquakes that ratted southwestern Japan last week injured around 1,100 people in Kumamoto and Oita prefectures and led to the deaths of another 58. Roughly 103,000 people remained displaced in Kumamoto and around 600 in Oita, and the authorities are still searching for people who are unaccounted for as well. What's more, due to heavy rains and the subsequent risk of landslides, some 240,000 people have been advised to evacuate 19 cities, towns and villages in Kumamoto and Oita.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

April 13, 2012

Chagas is a neglected disease that affects between eight and ten million people, mainly in Latin America. Doctors Without Borders/Médecins Sans Frontières (MSF) works in Paraguay's rural Chaco region, going into isolated communities to educate people about the disease and screen them for it. Internationally, MSF fights to improve access to diagnosis and treatment for the disease and advocates for more research and development into its treatment.

All photos by Anna Surinyach

April 05, 2012

In Paraguay, Doctors Without Borders/Médecins Sans Frontières (MSF) is covering the rural Chaco region, encouraging people to be tested and treated for Chagas, a widespread but little known and potentially fatal disease.

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

October 04, 2011

This crisis could have been prevented but the major player involved, the Brazilian Ministry of Health, has shirked its responsibilities and is evidently unwilling to overcome the various challenges. 

October 03, 2011

Chagas disease, or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi (T. cruzi) and is transmitted mainly by insects called triatomines, also known as ‘assassin bugs’ or ‘kissing bugs’. It is endemic in 21 Latin American countries and cases have also been reported in the U.S., Europe, and Japan.

Pages